125 related articles for article (PubMed ID: 1271246)
1. Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.
Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
J Pharm Sci; 1976 Apr; 65(4):502-507. PubMed ID: 1271246
[TBL] [Abstract][Full Text] [Related]
2. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
Dreyfuss J; Shaw JM; Ross JJ
J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of the depot antipsychotics.
Jann MW; Ereshefsky L; Saklad SR
Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
Curry SH; Whelpton R; de Schepper PJ; Vranckx S; Schiff AA
Br J Clin Pharmacol; 1979 Apr; 7(4):325-31. PubMed ID: 444352
[TBL] [Abstract][Full Text] [Related]
5. Depot fluphenazine enanthate and decanoate: comparative rates of release in dogs.
Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
J Pharm Pharmacol; 1975 Oct; 27(10):791-2. PubMed ID: 241800
[No Abstract] [Full Text] [Related]
6. [Pharmacological studies of long-acting phenothiazines with particular reference to fluphenazine decanoate (author's transl)].
Chen PC
Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):871-83. PubMed ID: 570538
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacokinetics of haloperidol decanoate. Comparison with other prolonged-action neuroleptics].
Levron JC; Ropert R
Encephale; 1987; 13(2):83-7. PubMed ID: 2885172
[TBL] [Abstract][Full Text] [Related]
8. Depot fluphenazine decanoate and enanthate for schizophrenia.
David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
[TBL] [Abstract][Full Text] [Related]
9. Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog.
Dreyfuss J; Ross JJ; Schreiber EC
J Pharm Sci; 1971 Jun; 60(6):829-33. PubMed ID: 5128931
[No Abstract] [Full Text] [Related]
10. The roles of depot injection sites and proximal lymph nodes in the presystemic absorption of fluphenazine decanoate and fluphenazine: ex vivo experiments in rats.
Luo JP; Hubbard JW; Midha KK
Pharm Res; 1998 Sep; 15(9):1485-9. PubMed ID: 9755905
[TBL] [Abstract][Full Text] [Related]
11. behavior of rats and mice administered active metabolites of fluphenazine, 7-hydroxy-fluphenazine and fluphenazine-sulfoxide.
Yamada K; Furukawa T
Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):76-85. PubMed ID: 7194019
[TBL] [Abstract][Full Text] [Related]
12. Study of accumulation of fluphenazine enanthate and fluphenazine decanoate, long-acting neuroleptic drugs, after repeated administrations by means of their inhibitory effects on the discriminated avoidance response in rats.
Kuribara H; Tadokoro S
J Toxicol Sci; 1979 May; 4(2):87-98. PubMed ID: 501762
[No Abstract] [Full Text] [Related]
13. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
Luo JP; Hubbard JW; Midha KK
Pharm Res; 1997 Aug; 14(8):1079-84. PubMed ID: 9279892
[TBL] [Abstract][Full Text] [Related]
14. Depot perphenazine decanoate and enanthate for schizophrenia.
Quraishi S; David A
Cochrane Database Syst Rev; 2000; (2):CD001717. PubMed ID: 10796445
[TBL] [Abstract][Full Text] [Related]
15. New concept in phenothiazine therapy: fluphenazine enanthate and fluphenazine decanoate.
Sanseigne AJ; Yale HL; Hess SM; Burke JC; Horovitz ZP
Agressologie; 1968; 9(2):309-13. PubMed ID: 5675497
[No Abstract] [Full Text] [Related]
16. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
[TBL] [Abstract][Full Text] [Related]
17. Fluphenazine enanthate in sesame oil, a depot preparation.
Rasmussen OS
Acta Psychiatr Scand; 1970; 46(3):311-8. PubMed ID: 5490593
[No Abstract] [Full Text] [Related]
18. Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection.
Ohura K; Nakada Y; Imai T
J Pharm Sci; 2023 Jul; 112(7):1975-1984. PubMed ID: 37019360
[TBL] [Abstract][Full Text] [Related]
19. Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
Yamada K; Furukawa T
Pharmacology; 1982; 24(3):147-55. PubMed ID: 7200248
[TBL] [Abstract][Full Text] [Related]
20. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
